Skip to main content

CAH Cardinal Health, Inc.

Healthcare

250.48 Close 10/30
Since 2024-12-02 +109.4%
Open
255.02
High
259.84
Low
250.12
Prev close
251.09
Volume
1.9M
Amplitude
3.87%
P/E
34.6
Revenue YoY (TTM)
+14.2%
52W 180.45 259.84

Is Cardinal Health, Inc. a buy? Fundamentals and valuation first

As of 2026-10-30

Valuation: Fair, Growth: Good, Momentum: Good, Risk / liquidity: Strong; Quality: Weak.

Valuation Fair Free-cash-flow yield is Good, but TTM P/E is Pricey.
TTM P/E 34.64 73th percentile Pricey
Price / book -20.21 N/A
Free-cash-flow yield (%) 7.77 76th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Weak FCF margin, TTM is Average; ROE, TTM is Lagging.
ROE, TTM (%) -59.45 16th percentile Lagging
Operating margin, TTM (%) 1.03 38th percentile Average
FCF margin, TTM (%) 1.78 43th percentile Average
Quality Factor Investing: A US Quality Value Backtest
Growth Good All 2 indicators are Good.
Revenue growth, TTM YoY (%) 14.23 68th percentile Good
Diluted EPS growth, TTM YoY (%) 12.09 62th percentile Good
Momentum Good 60-day return is Top; 240-day return is Good.
60-day return (%) 5.63 81th percentile Top
240-day return (%) 23.1 74th percentile Good
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Strong 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 390,923,860 96th percentile Top
60-day annualized volatility (%) 24.04 27th percentile Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Cardinal Health, Inc. (CAH) today

2 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Cardinal Health, Inc. to every stock like it

AI finds several complementary traits of Cardinal Health, Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Cardinal Health, Inc.

Cardinal Health, Inc. (CAH) peers and tracking

Watchlist

This page refreshes daily after the close. Add Cardinal Health, Inc. to your watchlist to track signal changes on your next visit.

Cardinal Health, Inc. (CAH) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 83.02%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
20 historical occurrences (since 2019-02-07)

Average forward return after Top-quintile 6-month momentum

20-day: Win 63.2%, Sample 19, Median +1.36%, Excess -0.71%, Beat mkt rate 47.4%

60-day: Win 68.4%, Sample 19, Median +9.1%, Excess +7.06%, Beat mkt rate 78.9%

120-day: Win 73.7%, Sample 19, Median +14.53%, Excess +5.94%, Beat mkt rate 52.6%

120 days after: historical avg +13.33%

20-day +0.63%
60-day +8.24%
120-day +13.33%
20-day
60-day
120-day
Win
63.2%
68.4%
73.7%
Sample
19
19
19
Median
+1.36%
+9.1%
+14.53%
Excess
-0.71%
+7.06%
+5.94%
Beat mkt rate
47.4%
78.9%
52.6%

Over 19 occurrences, 120-day forward avg gained 13.33%, beat the market by 5.94 pts; win rate 73.7%.

Filed revenue acceleration

Active · now 14.23%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

7 historical occurrences (since 2022-05-05)

Average forward return after Filed revenue acceleration

20-day: Win 14.3%, Sample 7, Median -1.42%, Excess -2.75%, Beat mkt rate 28.6%

60-day: Win 66.7%, Sample 6, Median +6.39%, Excess +2.28%, Beat mkt rate 66.7%

120-day: Win 100%, Sample 6, Median +19.38%, Excess +11.59%, Beat mkt rate 66.7%

120 days after: historical avg +18.28%

20-day -1.94%
60-day +5.11%
120-day +18.28%
20-day
60-day
120-day
Win
14.3%
66.7%
100%
Sample
7
6
6
Median
-1.42%
+6.39%
+19.38%
Excess
-2.75%
+2.28%
+11.59%
Beat mkt rate
28.6%
66.7%
66.7%

Over 6 occurrences, 120-day forward avg gained 18.28%, beat the market by 11.59 pts; win rate 100%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 19Insufficient data
20-40 233+43% +13.8% 62.2% +34.3%
40-60 133+58.9% +64.4% 97% +41.5%
60-80 You are here321+43.6% +42.6% 100% +28.3%
80-100 310+48.4% +25.1% 100% +29.8%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 34.64, placing it in the 75.7 own-history percentile, inside the 60-80 bucket.

More history: Valuation × momentum analogs, Market-wide momentum baseline, Signals not active now

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
+13.7%
Win rate 47.4% Excess +4.8%
133d
+22.8%
Win rate 98.8% Excess +12.8%
241d
Now
+16.7%
Win rate 78.5% Excess +8.7%
452d
60-day momentum down
+26.2%
Win rate 58.6% Excess +23.1%
87d
+37.5%
Win rate 95.4% Excess +33.5%
65d
+19.1%
Win rate 98.7% Excess +11.9%
158d

Currently in “Expensive (own-history top third) × 60-day momentum up”: across 452 historical days, 120-day forward avg gained 16.7%, win rate 78.5%, beat the market by 8.7%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

25 times historically; 60-day forward avg +3.07%, win rate 68.2%, beating the market by -0.1 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest

32 times historically; 60-day forward avg +1.98%, win rate 55.2%, beating the market by -2.28 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.